TECH - バイオテクネ （Bio-Techne Corp）TECHのニュース
American International Group Inc. Increases Stock Position in Bio-Techne Co. (NASDAQ:TECH) 2023/06/05 11:17:13 The AM Reporter
American International Group Inc. increased its position in shares of Bio-Techne Co. (NASDAQ:TECH – Get Rating) by 283.8% during the fourth quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 43,395 shares of the biotechnology company’s stock after buying an additional 32,089 shares during the period. American International […]
Bio-Techne Co. (NASDAQ:TECH) Stock Holdings Increased by Raymond James Financial Services Advisors Inc. 2023/06/05 10:39:50 The AM Reporter
Raymond James Financial Services Advisors Inc. lifted its stake in Bio-Techne Co. (NASDAQ:TECH – Get Rating) by 312.4% in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 4,087 shares of the biotechnology company’s stock after purchasing an additional 3,096 shares during the quarter. […]
BIO-TECHNE TO PRESENT AT THE 2023 JEFFERIES HEALTHCARE CONFERENCE 2023/05/25 11:00:00 PR Newswire
MINNEAPOLIS, May 25, 2023 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today announced that Jim Hippel, Executive Vice President and Chief Financial Officer, will present at the 2023 Jefferies Healthcare Conference on Thursday, June 8, 2023, at 12:30 p.m. EDT. A live webcast of…
Bio-Techne Corporation: Long-Term Quality, But At A Price 2023/05/18 22:42:08 Seeking Alpha
Bio-Techne Corporation has been a long term value creator, combining organic growth with sound M&A deals. Click here to read my analysis of TECH stock.
Thursday Is Your Last Chance To Buy Bio-Techne Before The Dividend Payout 2023/02/07 14:45:50 Benzinga
Thursday marks the last chance for investors to receive the next dividend payout from Bio-Techne (NASDAQ: TECH ). What''s Happening The company announced on Thursday that it would pay shareholders a quarterly dividend of 8 cents per share. On Friday, Bio-Techne will go ex-dividend, meaning the stock will trade lower to reflect that payout. In other words, the stock will … Full story available on Benzinga.com
Bio-Techne Corp. PT Lowered to $100 at Craig-Hallum 2023/02/03 14:46:11 Investing.com
https://www.investing.com/news/pro/biotechne-corp-pt-lowered-to-100-at-craighallum-432SI-2995119
Bio-Techne Corporation (TECH) Q2 2023 Earnings Call Transcript 2023/02/02 16:51:02 Seeking Alpha
Bio-Techne Corporation (NASDAQ:NASDAQ:TECH) Q2 2023 Earnings Conference Call February 2, 2023 9:00 AM ETCompany ParticipantsDavid Clair - Vice President of Investor RelationsChuck Kummeth -…
Bio-Techne declares $0.08 dividend 2023/02/02 11:46:40 Seeking Alpha
Bio-Techne (NASDAQ:TECH) declares $0.08/share quarterly dividend, in-line with prior dividend of $0.32 (adjusting for 4 for 1 stock split).Forward yield 0.39%Payable Feb.
Bio-Techne GAAP EPS of $0.31 misses by $0.03, revenue of $271.58M misses by $18.15M 2023/02/02 11:36:07 Seeking Alpha
Bio-Techne press release (TECH): Q2 GAAP EPS of $0.31 misses by $0.03.Revenue of $271.58M (+0.9% Y/Y) misses by $18.15M.
Bio-techne Corp Common Stock TECH Trading Signals 2023/01/04 09:45:00 Stock Traders Daily
Buy and Sell Signals for Bio-techne Corp Common Stock TECH that help investors manage their investment in TECH
BIO-TECHNE TO PRESENT AT THE 41st ANNUAL J.P. MORGAN HEALTHCARE CONFERENCE 2022/12/21 12:00:00 PR Newswire
MINNEAPOLIS, Dec. 21, 2022 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today announced that Chuck Kummeth, President and Chief Executive Officer, will present at the 41st Annual J.P. Morgan Healthcare Conference on Wednesday, January 11, 2023, at 8:15 a.m. PST. A live webcast of…
Stem Cell Assay Global Market Report 2022: Ukraine-Russia War Impact 2022/12/12 11:33:00 GlobeNewswire
Major players in the stem cell assay market are Thermo Fisher Scientific Inc. , Merck Group, Danaher Corporation, Becton Dickinson and Company, Bio-Rad Laboratories, PerkinElmer, Agilent Technologies, Promega Biotechnology Company, Cell Biolabs, Miltenyi Biotec, STEMCELL Technologies, Bio-Techne Corporation, Charles River Laboratories International Inc. Major players in the stem cell assay market are Thermo Fisher Scientific Inc. , Merck Group, Danaher Corporation, Becton Dickinson and Company, Bio-Rad Laboratories, PerkinElmer, Agilent Technologies, Promega Biotechnology Company, Cell Biolabs, Miltenyi Biotec, STEMCELL Technologies, Bio-Techne Corporation, Charles River Laboratories International Inc.